Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001014100-08-000046
Filing Date
2008-04-02
Accepted
2008-04-02 15:13:24
Documents
1
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 pol4.html 3  
1 pol4.xml 3 3377
  Complete submission text file 0001014100-08-000046.txt   5390
Mailing Address 2200 WILSON BLVD. SUITE 102-316 ARLINGTON VA 22201
Business Address 2200 WILSON BLVD SUITE 102-316 ARLINGTON VA 22201 703-526-0400
CHAMPIONS BIOTECHNOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 233 EAST REDWOOD ST BALTIMORE MD 21202
Business Address 410-576-4067
Poliakoff Abba David (Reporting) CIK: 0001423066 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17263 | Film No.: 08733141